Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Only 5.9% Spurious...

Only 5.9% Spurious Drug Cases Resolved: Parliamentary Panel Slams Govt

Farhat NasimWritten by Farhat Nasim Published On 2024-12-23T17:17:27+05:30  |  Updated On 23 Dec 2024 5:17 PM IST
CDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality Checks
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Take stringent action in a time bound manner for exemplary punishments for spurious/adulterated drugs, the Parliamentary Standing Committee on Chemicals and Fertilizers has recommended the Department of Pharmaceuticals (DoP).

The panel has expressed deep concerns about the low-resolution rate and inefficiencies in addressing cases related to spurious and adulterated drugs in the country.

The Committee’s findings and recommendations were outlined in its fifth report on the ‘Demands for Grants’ of the Department of Pharmaceuticals (DoP) for the fiscal year 2024-25, presented in the Lok Sabha.

Key Findings on Spurious and Adulterated Drugs

The Committee noted that Between 2015-16 and 2018-19, 2.3 lakh drug samples were tested by State Drugs Controllers. Out of these, 593 samples were declared spurious, and 9,266 were found to be of substandard quality. Shockingly, only 35 convictions were made, amounting to a mere 5.9% resolution rate. The Department of Pharmaceuticals clarified that this figure represents the percentage of cases decided and not the conviction rate, as conviction data is not maintained centrally. The Committee noted with concern that most of the 593 cases related to spurious or adulterated drugs remain unresolved and are still pending in various courts.

The DoP stated that State Drug Controllers conduct random drug sampling every month. Based on the analysis, actions such as issuing show-cause notices, stop-production orders, and suspending or cancelling licenses are taken under the Drugs Rules, 1945. Additionally, the Central Drugs Standard Control Organization (CDSCO) and the Ministry of Health and Family Welfare have implemented several measures to improve drug quality and safety. These include risk-based inspections of over 400 drug manufacturing premises, resulting in more than 300 actions, such as suspension or cancellation of licenses.

Amendments to the Drugs Rules, 1945, have been introduced to enhance compliance with Good Manufacturing Practices (GMP). Larger manufacturers must implement these revised standards within six months, while smaller and medium-sized manufacturers have a 12-month timeline. Furthermore, regulations now require top drug brands and active pharmaceutical ingredients (APIs) to include bar codes or QR codes on their packaging for better traceability. Marketers of drugs are also held accountable for quality and regulatory compliance.

The Committee, however found the Department’s reply on the higher prevalence of Not of Standard Quality (NSQ) drugs from Government sources did not address the core reasons for the issue.

Also Read: Thane: Spurious drugs worth Rs 1.85 crore seized, 2 booked

Concerns About Delays and Lack of Centralized Data

The Committee expressed surprise at the absence of centralized data on conviction rates for spurious and adulterated drugs. The panel headed by Member of Parliament Kirti Jha Azad said;

"The Committee are surprised to find that the conviction rate data is not maintained centrally for penal action for spurious/adulterated drugs."

The report added;

"The Committee are concerned about the delays in disposal of cases as also the maintenance of centralized data pertaining to enforcement of penalties for spurious/adulterated drugs. The Committee, therefore recommend stringent action to be taken in a time bound manner for exemplary punishments for spurious/adulterated drugs."

Higher Prevalence of Substandard Drugs in Government Channels

The Panel further noted with serious concern that the National Survey of Drugs (2014–16) revealed that 10% of samples from government sources were substandard, compared to only 3% from private sources—a 3.17 times higher prevalence in government channels than in the retail market. The Committee observed that this discrepancy;

“undoubtedly pointing to loopholes in the procurement processes.”

Though various measures are taken by the Ministry of Health and Family Welfare to ensure that better quality and more effective, and safe drugs are made available to consumers. The Committee, however, found the Department’s reply on the higher prevalence of Not of Standard Quality (NSQ) drugs from Government sources did not address the core reasons for the issue.

Recommendations for Comprehensive Measures

The Committee demanded a detailed explanation of the challenges, flaws, and enabling factors contributing to the higher prevalence of NSQ drugs from government sources. The report read;

"The Committee, therefore, demands a detailed explanation of the challenges, flaws, and enabling factors contributing to the higher prevalence of NSQ drugs from Government sources."

Furthermore, the Committee found the Department’s response does not outline the measures in place to ensure the quality and integrity of pharmaceutical products throughout all stages of the distribution process, including procurement, purchasing, storage, distribution, transportation, 85 documentation, and record-keeping.

The Panel said;

"The Committee desires that the Government come out with more clarity on the previous legal authority and enforceability of the rules governing these distribution guidelines so that accountability be fixed accordingly."
spurious drugsadulterated drugsparliamentary standing committeedepartment of pharmaceuticalssubstandard drugsstate drug controllerscentral drugs standard control organizationcdsconot of standard qualitynsq drugsdoppunishment
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 28/May/2025

    Health Bulletin 28/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok